Clinical trial
Drug-resistance Testing in Kenya to Improve ART Suppression of HIV Replication
NCT01898754 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug-resistance Testing in Kenya to Improve ART Suppression of HIV Replication
- Lead sponsor
- University of Washington
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- February 28, 2017
- Enrollment
- 991 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hiv positive